Stockreport

Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]

Surrozen, Inc.  (SRZN) 
PDF Initial capital funds expansion of Phase 1b trial in severe alcohol-associated hepatitis and extends cash runway Phase Ib data in expanded study expected in 1H 2025 [Read more]